Lithium overcomes the influence of 5-HTTLPR gene polymorphism on antidepressant response to sleep deprivation.
Benedetti
Francesco
F
Barbini
Barbara
B
Bernasconi
Alessandro
A
Fulgosi
Mara Cigala
MC
Campori
Euridice
E
Colombo
Cristina
C
Dallaspezia
Sara
S
Lorenzi
Cristina
C
Pontiggia
Adriana
A
Radaelli
Daniele
D
Smeraldi
Enrico
E
D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use*; D039721:Diagnostic and Statistical Manual of Mental Disorders; D005260:Female; D006801:Humans; D018020:Lithium Compounds / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010869:Pindolol / Q000627:therapeutic use; D011110:Polymorphism, Genetic; D011569:Psychiatric Status Rating Scales / Q000706:statistics & numerical data; D011618:Psychotic Disorders / Q000150:complications / Q000188:drug therapy; D058829:Serotonin 5-HT1 Receptor Antagonists; D012702:Serotonin Antagonists / Q000627:therapeutic use; D050486:Serotonin Plasma Membrane Transport Proteins / Q000235:genetics*; D012892:Sleep Deprivation / Q000150:complications / Q000188:drug therapy*; D016896:Treatment Outcome
D000928:Antidepressive Agents; D018020:Lithium Compounds; C493230:SLC6A4 protein, human; D058829:Serotonin 5-HT1 Receptor Antagonists; D012702:Serotonin Antagonists; D050486:Serotonin Plasma Membrane Transport Proteins; D010869:Pindolol